UNITES STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 23, 2012

 

 

Medtronic, Inc.

(Exact name of Registrant as Specified in its Charter)

 

 

 

Minnesota   1-7707   41-0793183

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

710 Medtronic Parkway Minneapolis, Minnesota   55432
(Address of principal executive offices)   (Zip Code)

(Registrant’s telephone number, including area code): (763) 514-4000

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders

On August 23, 2012, Medtronic, Inc. (the “Company”) held its 2012 Annual Meeting of Shareholders (the “Annual Meeting”) to: (1) elect ten directors each for a one-year term; (2) ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2013; (3) approve, in a non-binding advisory vote, named executive officer compensation; (4) amend and restate the Company’s Articles of Incorporation to provide for a majority vote in uncontested elections of directors; (5) consider and vote upon a shareholder proposal entitled “Proxy Access”; and (6) consider and vote upon a shareholder proposal entitled “Adopt Simple Majority Vote.”

At the close of business on June 25, 2012, the record date of the Annual Meeting, the Company had 1,025,039,711 shares of common stock issued and outstanding. The holders of a total of 852,418,500 shares of common stock were present at the Annual Meeting, either in person or by proxy, which total constituted a majority of the issued and outstanding shares on the record date of the Annual Meeting.

The final voting results and the votes used to determine the results for each proposal are set forth below:

 

  1. The shareholders elected each of the ten nominees to the Board of Directors to serve for one-year terms, as follows:

 

     For      For (Percent of
Shares Voted)
    Withheld      Withheld
(Percent of
Shares
Voted)
    Broker Non-Vote  

Richard H. Anderson

     723,395,506         97.02     22,250,249         2.98     106,772,745   

Victor J. Dzau, M.D.

     652,916,111         87.56     92,729,644         12.44     106,772,745   

Omar Ishrak

     723,068,313         96.97     22,577,442         3.03     106,772,745   

Shirley Ann Jackson, Ph.D.

     662,509,756         88.85     83,135,999         11.15     106,772,745   

Michael O. Leavitt

     739,751,450         99.21     5,894,305         0.79     106,772,745   

James T. Lenehan

     740,079,642         99.25     5,566,113         0.75     106,772,745   

Denise M. O’Leary

     723,306,621         97.00     22,339,134         3.00     106,772,745   

Kendall J. Powell

     723,917,611         97.09     21,728,144         2.91     106,772,745   

Robert C. Pozen

     738,742,306         99.07     6,903,449         0.93     106,772,745   

Jack W. Schuler

     641,073,069         85.98     104,572,686         14.02     106,772,745   

 

  2. The shareholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2013 fiscal year.

 

     Votes      Percent of SharesVoted  

For

     839,550,771         98.49

Against

     10,660,859         1.25

Abstain

     2,206,870         0.26

 

  3. The shareholders approved, on a non-binding advisory basis, the compensation awarded to the Company’s named executive officers.

 

     Votes      Percent of SharesVoted  

For

     605,321,988         81.18

Against

     135,837,536         18.22

Abstain

     4,486,231         0.60

Broker Non-Vote

     106,772,745         N/A   


  4. The shareholders did not approve the proposal to amend and restate the Company’s Articles of Incorporation to provide for majority vote in uncontested elections of directors.

 

     Votes      Percent of Shares
Outstanding
 

For

     739,186,029         72.11

Against

     4,772,808         0.47

Abstain

     1,686,918         0.16

Broker Non-Vote

     106,772,745         N/A   

 

  5. The shareholders did not approve the shareholder proposal entitled “Proxy Access.”

 

     Votes      Percent of Shares Voted  

For

     54,857,884         7.36

Against

     686,472,701         92.06

Abstain

     4,315,170         0.58

Broker Non-Vote

     106,772,745         N/A   

 

  6. The shareholders approved the shareholder proposal entitled “Adopt Simple Majority Vote.”

 

     Votes      Percent of Shares Voted  

For

     492,177,485         66.01

Against

     250,291,934         33.57

Abstain

     3,176,336         0.43

Broker Non-Vote

     106,772,745         N/A   


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

MEDTRONIC, INC.

 

  By   /s/ D. Cameron Findlay
Date: August 28, 2012     D. Cameron Findlay
   

Senior Vice President, General Counsel

and Corporate Secretary